Pulse Biosciences (NASDAQ:PLSE) Shares Gap Up – Time to Buy?

Pulse Biosciences, Inc. (NASDAQ:PLSEGet Free Report) shares gapped up before the market opened on Friday . The stock had previously closed at $15.66, but opened at $16.36. Pulse Biosciences shares last traded at $16.13, with a volume of 55,647 shares.

Wall Street Analysts Forecast Growth

Separately, StockNews.com raised Pulse Biosciences to a “sell” rating in a report on Thursday, January 2nd.

Get Our Latest Stock Analysis on Pulse Biosciences

Pulse Biosciences Stock Performance

The firm has a 50 day simple moving average of $18.83 and a 200-day simple moving average of $18.17.

Institutional Trading of Pulse Biosciences

Several hedge funds have recently modified their holdings of the company. Tower Research Capital LLC TRC raised its position in Pulse Biosciences by 98.1% in the 4th quarter. Tower Research Capital LLC TRC now owns 1,692 shares of the company’s stock valued at $29,000 after purchasing an additional 838 shares during the last quarter. KLP Kapitalforvaltning AS acquired a new stake in shares of Pulse Biosciences in the fourth quarter valued at $44,000. Caisse Des Depots ET Consignations bought a new position in shares of Pulse Biosciences in the fourth quarter valued at about $95,000. Farther Finance Advisors LLC lifted its position in Pulse Biosciences by 44.4% during the 4th quarter. Farther Finance Advisors LLC now owns 7,220 shares of the company’s stock worth $126,000 after buying an additional 2,220 shares in the last quarter. Finally, SG Americas Securities LLC bought a new stake in Pulse Biosciences during the 4th quarter worth about $193,000. Institutional investors and hedge funds own 76.95% of the company’s stock.

Pulse Biosciences Company Profile

(Get Free Report)

Pulse Biosciences, Inc operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology.

See Also

Receive News & Ratings for Pulse Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pulse Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.